Plné znění - 2/2008 Sb. m. s.

Xxxxxxxxxxxx xxxxxxxxxxxx xxxx xxxxxxx, že xxx 16. xxxxxxxxx 2007 xxxx generálním xxxxxxxxx XXXXXX, depozitářem Xxxxxxxxxxx xxxxxx proti xxxxxxx xx xxxxxx¹⁾, xxxxxxxx schválení nového xxxxx Přílohy I - Xxxxxxx xxxxxxxxxx xxxxx x xxxxx xxxxxxx.

Xxxxxxx I xxxxxxxxx x platnost x xxxxxxx x článkem 34 xxxx. 3 Úmluvy xxx 1. ledna 2008 x xxxxx xxxx xxxxxxxxx v xxxxxxxx x pro Xxxxxx xxxxxxxxx. Xxxx xxxxxx Přílohy X x platnost xxxxxxxx xxxxxx Xxxxxxx X Xxxxxxxxxxx úmluvy proti xxxxxxx xx xxxxxx xx xxxxx pro xxx 2007, xxxxxxxxx xxx x. 59/2007 Xx. x. s.

Xxxxxxxx xxxxx Přílohy X x xxxx xxxxxxx xx xxxxxxx xxxxxx xx xxxxxxxxx xxxxxxxx.

X1. XXXXXXXXXX XXXXX

Xxxxxxxxxx xxxxx jsou xxxxxxxx.

1. XXXXXXXXXX XXXXXXXXXX STEROIDY (XXX):

x. Xxxxxxxx * XXX, xxxxxxxxxx:

1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3β,17β-xxxx); 1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3,17-xxxx); xxxxxxxxx (19-norandrostendiol); xxxxxxxxxx; xxxxxxxx; boldion (xxxxxxxx-1,4-xxxx-3,17-xxxx); xxxxxxx (17α-ethynyl-17β-hydroxyandrost-4-eno[2,3-d]isoxazol); dehydrochlormethyltestosteron (4-xxxxxx-17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxxxxxxxxxxxxxxxx (17α-xxxxx-5α-xxxxxxx-2-xx-17β-xx); xxxxxxxxxxx; ethylestrenol (19-nor-17α-pregn-4-en-17-ol); xxxxxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxxxxx[2,3-x]-xxxxxxx); gestrinon; 4-xxxxxxxxxxxxxxxxxx (4,17β-xxxxxxxxxxxxxxxx-4-xx-3-xx); xxxxxxxxxx; klostebol; xxxxxxxxxx; mesterolon; metandienon (17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxx; xxxxxxxxxxx; xxxxxxxxxx (2α, 17α-xxxxxxx-5α-xxxxxxxxx-3-xx-17β-xx); xxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9-xxxx-3-xx); methyl-1-testosteron (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxxx (17β-hydroxy-17α-metylestr-4-en-3-on); xxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9,11-xxxxx-3-xx); xxxxxxxxxxxxxxxxx; xxxxxxxxx; xxxxxxxxx; 19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx); xxxxxxxxxx; xxxxxxxxxxxxxx; xxxxxxxxxxxx; xxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx; xxxxxxxxxx; prostanozol ([3,2-x]xxxxxxx-5α-xxxxxxxxxxxxxx-17β-xxxxxxxxxxxxxxxxx); quinbolon; xxxxxxxxxx; xxxxxxxxx; 1-xxxxxxxxxxx (17β-xxxxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxx (18α-xxxx-xxxxxx-4,9,11-xxxxx-17β-xx-3-xx); trenbolon x xxxxx látky x xxxxxxxx chemickou xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

x. Xxxxxxxxx ** XXX:

Xxxxxxxxxxxxx (androst-5-en-3β,17β-diol), xxxxxxxxxxxxx (xxxxxxx-4-xx-3,17-xxxx), dihydrotestosteron, prasteron (xxxxxxxxxxxxxxxxxxxxx, XXXX), xxxxxxxxxxx x xxxxxxxxxxx metabolity x isomery:

5α-xxxxxxxxx-3α,17α-xxxx xxxxxxx-5-xx-3β,17α-xxxx

5α-xxxxxxxxx-3α,17β-xxxx 4-xxxxxxxxxxxxx (androst-4-en-3β,17β-diol)

5α-xxxxxxxxx-3β,17α-xxxx 5-xxxxxxxxxxxxx (xxxxxxx-5-xx-3,17-xxxx)

5α-xxxxxxxxx-3β,17β-xxxx xxx-xxxxxxxxxxxxxxxxxx

xxxxxxx-4-xx-3α,17α-xxxx 3α-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-4-xx-3α,17β-xxxx 3β-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-5-xx-3β,17α-xxxx 19-xxxxxxxxxxxxxx

androst-5-en-3α,17α-diol 19-noretiocholanolon

xxxxxxx-5-xx-3α,17β-xxxx

X xxxxxxxxx, xxx xxxx xxxx produkovat xxxxxxxxxx xxxxxxxxxx xxxxxxx přirozeně, xxxx se xxx xx to, xx Xxxxxx obsahuje xxxx Xxxxxxxxx látku x xxxx hlášen pozitivní Xxxxxxxxx xxxxxxxxxxx xxxxx, xxxx xx xxxxxxxxxxx Xxxxxxxx látky nebo xxxxxx xxxxxxxxxx nebo xxxxxxxxxxx a/nebo xxxx xx xxxxxxxx jiný xxxxxxxxx poměr xx Xxxxxx Sportovce xxxxxxxx xxxxxxxxx od xxxxxxx xxxxxx, xxxxx xx xxxxxxxx xxxxxxxxx x xxxx xxx, xx xxxxxxxxxx normální xxxxxxxxx xxxxxxxx. Nebude xx xxx xx xx, xx Xxxxxx obsahuje Xxxxxxxxx látku v xxxxxxx případě, pokud Xxxxxxxxx xxxxxxx, xx xx koncentrace Xxxxxxxx xxxxx xxxx xxxxxx xxxxxxxxxx xxxx xxxxxxxxxx x/xxxx xxxxxxxxx xxxxx xx Vzorku Xxxxxxxxx xxxxxxxx xxxxxxxxxxxxx nebo xxxxxxxxxxxx xxxxxx.

Xxxx xx xxx xx xx, xx Vzorek Xxxxxxxxx xxxxxxxx Zakázanou xxxxx x xxxxxxxxx xxxxxxx Xxxxxxxxx laboratorní xxxxx xx všech xxxxxxxxx x xxx xxxxxxxxx koncentraci, xxxxx xxx xxxxx xxxxxxxxxx xxxxxxxxxx metody (např. XXXX) xxxxxxxx, xx xx Xxxxxxxx xxxxx xxxxxxxxxx xxxxxx. X xxxxxxx xxxxxxx xxxx xxxxx provádět xxxxx xxxxxxx.

Když xx xxxxxxx xxxxxxxx xxxxxxx xxxxxxxx xxxxxxxxxxx xx xxxxxxx xxxxxx, xxxxx xx xxxxxxxx xxxxxxxxx x xxxx x xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (např. IRMS) xxxxxxxxxxx xxxxxxxx původ Xxxxxxxx xxxxx, xxx xxxxxxxx xxxxxx xxxxxxx Xxxxxxxx xxxxx, xxxx xxxx. porovnání s xxxxxxxxxxx referenčními xxxxxxxxxxx xxxxxxx, xxxx xxxx xxxxxxxxx xxxxxxxxx xxxxx X/X xxxxx než xxxxx (4) xx xxxxx (1) a xxxxx xxxxxxxxxx analytická xxxxxx (xxxx. XXXX) xxxxxxxxxxx exogenní xxxxx xxxxx, provede xxxxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx další xxxxxxx xxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxx nebo xxxxxxxxxx xxxxxxxxxx xxxxx.

Xx-xx xxxxxxxxxx xxxxxx xxxxx xxxxxxx, xxx xxxxxxxx xxxx laboratoří xxxxxx jako xxxxxxxxx x xx jako xxxxxxxxx. Pokud laboratoř xxxxxxx, za xxxxxxx xxxxxxxxxx analytické xxxxxx (xxxx. XXXX) xxxxxxxx xxxxx Xxxxxxxx xxxxx, xxxx nutné xxxxxxxx xxxxx xxxxxxx, x xxxx se xxx xx xx, že Xxxxxx xxxxxxxx Zakázanou xxxxx. Pokud nebyla xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) x nejsou x xxxxxxxxx xxxxxxxxx 3 xxxxxxxxx xxxxx, xxxx xxxxxxx xxxxxxxxxxxxxx xxxxxx Xxxxxxxxx tím, xx xxxx xxxxxxxxxx Antidopingovou xxxxxxxxxx v xxxxxxxxxxxxx 3 xxxxxxxx xxxxxxx xxxxxxxx xxx xxxxxxxxxxx xxxxxxxx. Výsledek, který xxxxxxxxxx xxxx xxxxxxxxxxxxxx xxxxxx, bude xxxxxx xxxx xxxxxxxxx. Xxxxx xxxxxxxxxxxxxx profil Sportovce, xxxxxxxx xxxxxxxxxx testy, xxxx xxxxxxxxxxxx normální, xxxx se pak xxxxxxxxx xx Pozitivní xxxxxxxxxxx xxxxx.

V xxxxxxxx xxxxxxxx xxxxxxxxxxxxxx xxxxxxxxx xxxx být x xxxx xxxxxx xxxxxxx xxxxxxxx xxxxxxxxxxx xxxxxx ve velice xxxxxx xxxxxxxxxxxxx (xx/xx). Xxxxx laboratoř takový xxxxx xxxxxxxxx a xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxxxxx xxxxxxxx xxxxx Xxxxxxxx xxxxx, může xxx xxxxxxxxx další xxxxxxx provedením xxxxxxxxxx xxxxx (xxxxxxxxxx testů).

Xxxxx laboratoř xxxxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx 19-xxxxxxxxxxxxxxx, xxxx se xx xxxxxxxxx xx xxxxxxx a přesvědčivý xxxxx xxxxxxxxxx xxxxxx Xxxxxxxx látky. V xxxxxxx případě xxxx xxxxx xxxxxxxx další xxxxxxx.

X xxxxxxx, xx Xxxxxxxxx xxxxxx xxxxxxxxxxxxx xxx xxxxxxx xxxxxxxxx, xxxx se xxx za xx, xx Vzorek Xxxxxxxxx xxxxxxxx Zakázanou látku.

2. Xxxxxxx xxxxxxxxxx xxxxx, zahrnující:

Xxxxxxxxxxx, xxxxxxxxxx modulátory xxxxxxxxxxxxx xxxxxxxxx (XXXX), xxxxxxx, xxxxxxx, zilpaterol, ale xx x xxxxxxxx xxxxx xx xx.

S2. XXXXXXX X XXXXXXXX XXXXX

Xxxxxxxxxxx látky x xxxxxx xxxxxxxxxx xxxxxxx xxxx xxxxxxxx:

1. Erytropoetin (XXX);

2. Xxxxxxx xxxxxx (xXX), insulinu xxxxxxx xxxxxxx xxxxxxx (xxxx. XXX-1), xxxxxxxxxx xxxxxxx xxxxxxx (XXX);

3. Xxxxxxxxxxxxx (např. XX, xXX), xxxxxxxx jen x xxxx;

4. Xxxxxxxx;

5. Xxxxxxxxxxxxxx

x xxxxx xxxxx x podobnou xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx účinky.

Pokud Xxxxxxxxx xxxxxx xxxxxxxx, xx xxxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxxx či xxxxxxxxxxxx stavem, xxxx xx xxx xx xx, že Xxxxxx xxxxxxxx Zakázanou xxxxx (xxx je xxxxxxx xxxx) x xxxxxxxxx, xxx xxxxxxxxxxx Xxxxxxxx xxxxx xxxx jejích xxxxxxxxxx xx xxxxxxxxxx x/xxxx xxxxxxxxx poměry xx Vzorku Xxxxxxxxx xxxxxxx překročí hodnoty xxxxxxxx xxxxxxxx u xxxx tak, xx xxxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx.

Xxxxx laboratoř xxxxxxxxx, po xxxxx xxxxxxxxxx analytické metody, xx Zakázaná xxxxx xx exogenního xxxxxx, xxxx se xxx xx xx, xx Xxxxxx obsahuje Xxxxxxxxx xxxxx x xxxx xxxxxxx Pozitivní laboratorní xxxxx.

X3. XXXX-2 AGONISTÉ

Xxxxxxx xxxx-2 agonisté včetně xxxxxx X- x X-xxxxxxx xxxx xxxxxxxx.

Xxxxxxxx jsou xxxxxxxxxx, xxxxxxxxxx, salmeterol x xxxxxxxxxx, pro xxxxx xx xxx xxxxxxxx xxxxx xxxxxxx xxxxxxxx xxxxxxxxxxxx xxxxxxx.

I xxxx xxxx udělena xxxxxxxx xxxxx xxxxxxxxxxxx xxxxxxx, xxxx xxxxx xxxxxxxxxxx (xxxxx plus xxxxxxxxxx) xxxxx xxx 1000 nanogramů x 1 xxxxxxxxx xxxx xxxxxxxxx xx Xxxxxxxxx xxxxxxxxxxx nález, pokud Xxxxxxxxx xxxxxxxxx, že xxxxxxxxxx xxxxxxxx byl xxxxxxxx terapeutickým užíváním xxxxxxxxxxx x xxxxxxxx.

S4. XXXXXXXXXXX X MODULÁTORY HORMONŮ

Xxxxxxxxxxx xxxxxxx jsou xxxxxxxx:

1. Inhibitory xxxxxxxx, xxxxxxxxxx:

2. Xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx receptorů (XXXX), xxxxxxxx:

3. Xxxxxxx xxxxxxxxxxxxxx xxxxx xxxxxxxxxx:

4. Xxxxx modifikující xxxxxx xxxxxxxxxx včetně xxxxxxxxxx xxxxxxxxxx, xxx xx x xxxxxxxx xxxxx xx xx.

X5. XXXXXXXXX A XXXXXXX XXXXXXXXX XXXXX

Xxxxxxxxx xxxxx xxxx xxxxxxxx. Zahrnují:

Xxxxxxxxx*, epitestosteron, xxxxxxxxxx, xxxxxxxxxx alfa-reduktázy (xxxx. xxxxxxxxxx, xxxxxxxxxx), xxxxxxxxxxxxxxx (xxxx. xxxxxxx, xxxxxxx, xxxxxxxxxxxxxxxxx) x xxxxx xxxxx x podobnými xxxxxxxxxxxx xxxxxx.

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxxxxx, xxxxxxxx, xxxxxxxxx, furosemid, xxxxxxxxxxxx, xxxxxxxxx, xxxxxxxx, kyselina xxxxxxxxxx, metolazon, xxxxxxxxxxxxx, xxxxxxxx (např. xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx), triamteren x xxxxx látky x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx účinky (xxxxx xxxxxxxxxxxx, xxxxx není xxxxxxxx).

* Xxxxxxxxxxxx xxxxxxx xxxx xxxxxx, xxxxx xxx Xxxxxxxxx xxxxxxxx xxxxxxxxx xx xxxxxxx x prahovou xxxx xxxxxxxxxxx hladinou xxxx Zakázané xxxxx (xxxxx).

X1. XXXXXXXXX XXXXXXX XXXXXXX

Xxxxxxxx je xxxxxxxxxxx:

X2. XXXXXXXX X FYZIKÁLNÍ MANIPULACE

M3. XXXXXX XXXXXX

Xxxxxxxxxxxxxx xxxxxxx xxxxx, xxxx, xxxxxxxx xxxxxxxx, xxxx xxxxxxxxxx xxxxxxx xxxx, xxxxx xxxx schopnost xxxxxx xxxxxxxxx výkon, xx xxxxxxxx.

X6. XXXXXXXXXXX

Všechna xxxxxxxxxxx (xxxxxx xxxx xxxxxx xxxxxxxxxx xxxxxxxxx (X- a X-) xxxxxxx) xxxx xxxxxxxx, x xxxxxxxx derivátů xxxxxxxxx x případě xxxxxx místního užití x stimulancií xxxxxxxxxx xx Xxxxxxxxxxxxxx xxxxxxxx xxx rok 2008.

Xxxxxxxxxxx xxxxxxxx:

Xxxxxxxxx, xxxxxxxxx**, xxxxxxxxxx, amfetaminil, xxxxxxxxxx, amfetamin, xxxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxxxx, xxxxxxx****, xxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, famprofazon, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, fenkamfamin, xxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, fenproporex, xxxxxxxxx, 4-fenylpiracetam (karfedon), xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxx, xxxxx***, xxxxxxxxxxx, xxxxxx, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, mefentermin, xxxxxxxxxxxx, xxxxxxxxxxxx (X-), xxxxxxxxxxxx****, xxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxx, modafinil, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxx, oxilofrin, xxxxxxxxxxxxxxxxxxxx, xxxxxxx, xxxxxxxxxxx, x-xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, selegilin, xxxxxxxxxx, xxxxxxxxx, tuaminoheptan x xxxxx xxxxx x xxxxxxxx chemickou xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Xxxxxxxxxxxx xxxxxxxxx xxxxxxxx xxxx xxxxxxxx x xxxxx xxxxxx bude xxxxxxxxxx za xxxxxxxxxxx xxxxx xxxxx, xxxxx Xxxxxxxxx xxxxxxx, xx xxxx všeobecná xxxxxxxxxx x xxxxxxx léčebných xxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx pravidel, xxxx xx x xxx xxxxx pravděpodobnost, xx xxxx úspěšně xxxxxxxx xxxx xxxxxxxxx xxxxx.

S7. XXXXXXXXX

Xxxxxxxxxxx xxxxxxxxx xxxx zakázaná:

Xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx(xxxxxx), xxxxxxxx x xxxx xxxxxxxx, xxxxxxxxxxx, metadon, xxxxxx, xxxxxxxx, xxxxxxxxx, pentazocin, xxxxxxx.

S8. XXXXXXXXXXX

Xxxxxxxxxxx (xxxx. xxxxx, xxxxxxxxx) jsou xxxxxxxx.

X9. XXXXXXXXXXXXXXXXXXXX

Xxxxxxx xxxxxxxxxxxxxxxxxxxx xxxxxxxx orálně, rektálně, xxxxxxxxxx xxxx xxxxxxxxxxxxx xxxxxxxx jsou zakázané. Xxxxxx xxxxx xxxxxxxx xxxxxxxxxxxxx xxxxxxx.

Xxxx xxxxxxx xxxxxxxx aplikace (xxxxxxxxxxxx, xx okolí xxxxxx, do xxxxx xxxxxx, epidurální, xx xxxx) x xxxxxxxxx xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxxxxxxx výjimku x xxxxxxxx níže uvedených.

Xxxxxxx xxxxxxxxx xxxxxxxx xx xxxxxx kožní (xxxxxx iontoforézy/fonoforézy), xxxx, xxxxx, xxxx, xxxxxx xxxxx řitního otvoru, xxxxxxxx xxx a xxxxx nejsou zakázané x xxxxxxxxxx xxxxxx xxxxx terapeutické xxxxxxx.

X1. XXXXXXX

Xxxxxxx (xxxxxx) xx xxxxxxxx xxxxx Xxx soutěži x xxxxxxxxxxxxx xxxxxxxx. Xxxxxxx xx xxxx provádět xxxxxxxx xxxxxxxx x/xxxx xxxxxxxx xxxx. Prahová xxxxxxx xxx xxxxxxxx xxxxxxxxxxx pravidla (xxxxxxxxxxxxx xxxxxxx) xx xxx xxxxxx federaci uvedena x xxxxxxxxx.

∙ Xxxxxxxxxxxx sport (XXX) (0.10 x/x)

∙ Xxxxxx (XXX) (0.10 x/x)

∙ Letecké xxxxxx x xxxxxxxxxxxx (XXX) (0.20 g/l)

∙ Xxxxxxxxxxx (FITA, XXX) (0.10 x/x)

∙ Xxxxxxx pětiboj (XXXX) xxx pro xxxxxxxxxx xx střelbou (0.10 x/x)

∙ Xxxxxxxxxxx sport (XXX) (0.10 g/l)

∙ Xxxxx xxxxxxxxxx (XXX) (0.30 x/x)

∙ Xxxxxxx (IPC) (0.10 g/l)

X2. BETA-BLOKÁTORY

Xxxxx xxxx jinak určeno, xxxx-xxxxxxxxx xxxx xxxxxxxx xxxxx Xxx soutěži x xxxxxxxxxxxxx sportech.

∙ Xxxxxxxxxxxx xxxxx (XXX)

∙ Xxxxxxxx (XXXX)

∙ Xxxx (XXXX)

∙ Bridž (XXX)

∙ Curling (XXX)

∙ Gymnastika (XXX)

∙ Xxxxxxxx (XXXX) - "match xxxx" - jen xxxxxxxxxxx

∙ Xxxxxxx (XXX)

∙ Letecké xxxxxx a xxxxxxxxxxxx (XXX)

∙ Xxxxxxxxxxx (XXXX, IPC) (zakázané xxxx Mimo xxxxxx)

∙ Lyžování (FIS) - skoky xx xxxxxx x xxxxxxxxxxx xxxxxxxx-xxxxx x X-xxxxx, x xxxxxxxxx U-rampa x "xxx xxx"

∙ Xxxxxxx xxxxxxx (XXXX) - xxx xxxxxxxxxx xx střelbou

∙ Xxxxxxxxxxx xxxxx (XXX)

∙ Xxxxxxxx x xxxxxxx xxxxxx (XXXX, XXX "xxxxx")

∙ Xxxxxxx (XXXX, XXX) (xxxxxxxx xxxx Xxxx xxxxxx)

∙ Xxxxx motorismus (XXX)

∙ Xxxxx (FILA)

Xxxx-xxxxxxxxx zahrnují xxxxxxxxxxx xxxxx:

Acebutolol, xxxxxxxxxx, xxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxxx, karvedilol, labetalol, xxxxxxxxxxx, metipranolol, xxxxxxxxxx, xxxxxxx, oxprenolol, xxxxxxxx, xxxxxxxxxxx, xxxxxxx, xxxxxxx, xxx ne x xxxxxxxx pouze na xx

"Xxxxxxxxxx látky"* xxxx xxxxxxxxxxx xxxx:

∙ Xxxxxxx Xxxx-2 xxxxxxxx x xxxxxxxx, xxxxx xxxxxxxxxxx (volného xxxx xxxxxxxxxxx) xxx xxxxxxxx xxxxxx xxx 1000 ng/ml xxxx x xxxxxxxxxxxx (xxxxxxx xx xxxxxxx X 1.2 Xxxxxxx xxxxxxxxxx xxxxx);

∙ Xxxxxxxxxx xxxx-xxxxxxxxx, probenecid;

∙ Xxxxx, kropropamid, xxxxxxxxxx, xxxxxxx, xxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxxxxx, p-metylamfetamin, xxxxxxxxxxxx, niketamid, norfenefrin, xxxxxxxxx, ortetamin, xxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, sibutramin, xxxxxxxxxxxxx x xxxxxxx xxxxxxx stimulancia xxxxxxxxx xxxxxxxx x xxxxxx X6, xxx xxxxx Xxxxxxxxx prokáže, že xxxxxxx xxxxxxxx popsané x xxxxxx X6;

∙ Kanabinoidy;

∙ Xxxxxxx Xxxxxxxxxxxxxxxxxxxx;

∙ Xxxxxxx;

∙ Xxxxxxx Xxxx-xxxxxxxxx.

*"V Seznamu xxxxx xxx xxxxxxxxxxx xxxxxxxxxx xxxxx, které xxxxxxxx umožňuji neúmyslné xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx, xxxxxxx jsou xxxxxxxxx xxxxxxxx x xxxxxxx xxxxxxxxx xxxxxxxxxxx, xxxx x xxxxx xx xxxxx xxxxxxxxxxxxxxx, xx xxxxx úspěšně xxxxxxxx xxxx xxxxxxxxx xxxxxxx." Xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx xxxxx xxxx znamenat xxxxxxx xxxxxx xx předpokladu, xx "...Xxxxxxxxx xxxx xxxxx xxxxxxxx, xx Xxxxxxx xxxxxxxxxx látky xxxxxx zamýšleno xx xxxxxxx xxxxxxxxxxx xxxxxx...".

Xxxxxx xxxxxxx č. 2/2008 Xx. x. x. nabyl účinnosti xxxx 31.1.2008.

Xxxxxx xxxxxxx č. 2/2008 Xx. x. x. xxx xxxxxx xxxxxxx xxxxxxxxx č. 8/2009 Sb. m. s. x účinností xx 7.2.2009.

Znění xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx právních xxxxxxxx x odkazech xxxx xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx xxxxxxxxx xxxxx xxxxx uvedeného xxxxxxxx xxxxxxxx.